Status:

COMPLETED

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers

Lead Sponsor:

Emory University

Collaborating Sponsors:

Kaneka Medical America LLC

Conditions:

Familial Hypercholesterolemia

Eligibility:

All Genders

3-70 years

Brief Summary

The primary objective of this study is to measure how LDL apheresis affects levels of inflammatory and cholesterol markers in human beings. The investigators will address this question by drawing pre-...

Detailed Description

Numerous epidemiological investigations have demonstrated the importance of cholesterol - specifically low density lipoprotein (LDL) - in the development and progression of atherosclerosis. A continui...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Heterozygous FH with documented CAD and LDL-C ≥ 200 mg/dL Documented CAD may be represented as: Lesion(s) on coronary angiography, history of myocardial infarction, CABG, PTCA, progressive angina demonstrated by stress testing, history of other revascularization procedure (e.g. atherectomy)
  • Homozygous FH and LDL-C \> 500 mg/dL
  • Heterozygous FH and LDL-C ≥ 300 mg/dL
  • On stable LDL apheresis therapy for at least 6 months.
  • Exclusion criteria:
  • Patient refusal to participate
  • Inability to attend 2 consecutive LDL apheresis sessions for study duration
  • Subject with advanced renal disease
  • Subject with chronic progressive hepatic disease and demonstrated deficient synthetic function
  • Subject with acute hepatic process
  • Subject with current malignancy
  • Subject with diagnosis of amyloidosis
  • Subject with diagnosis of rheumatoid arthritis
  • Any subject with acute flare of chronic disease
  • Subject with recent ethanol ingestion
  • Subject with significant bone disease

Exclusion

    Key Trial Info

    Start Date :

    March 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2012

    Estimated Enrollment :

    8 Patients enrolled

    Trial Details

    Trial ID

    NCT01138371

    Start Date

    March 1 2011

    End Date

    March 1 2012

    Last Update

    December 17 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Emory University Hospital

    Atlanta, Georgia, United States, 30322